Medison buys majority interestin Austrian firm Kretztechnik

Article

3-D ultrasound scanner awaits U.S. clearanceKorean ultrasound manufacturer Medison has purchased a 60% interestin Austrian 3-D ultrasound developer Kretztechnik AG. The purchaseshould give Kretztechnik the staying power to weather what hasbeen

3-D ultrasound scanner awaits U.S. clearance

Korean ultrasound manufacturer Medison has purchased a 60% interestin Austrian 3-D ultrasound developer Kretztechnik AG. The purchaseshould give Kretztechnik the staying power to weather what hasbeen an agonizingly long 510(k) review process in the U.S. forits 3-D technology.

Kretztechnik was formed in 1947 and was one of the first ultrasounddevelopers. The company got a head start in 3-D ultrasound withits Combison 330 scanner, which integrated 3-D technology intoan ultrasound system. Other non-3-D Kretztechnik scanners includethe gray-scale Combison 311 and the color Doppler Combison 420.

Combison 311 is distributed in the U.S. by Cone Instruments ofSolon, OH, which also has rights to the 3-D system. The companieshad hoped that Food and Drug Administration clearance of Combison330 would be forthcoming in 1990 (SCAN 5/9/90). Kretztechnik latermade substantial changes to the technology, renamed the new systemCombison 530, and submitted a new 510(k) application to the FDAin 1994.

Two years later, Cone and Kretztechnik are still waiting for theagency's go-ahead on Combison 530. In the meantime, other ultrasoundcompetitors, such as Acoustic Imaging and TomTec, have receivedclearance for dedicated 3-D workstations. In addition, major ultrasoundvendors like ATL and Toshiba have developed 3-D ultrasound technologythat can be used with their conventionalscanners.

Perhaps due in part to the lack of U.S. sales for Combison 530,Kretztechnik ran into financial difficulties as sales and R&Dcosts increased, according to a Medison spokesperson. It beganlooking for a corporate partner in July 1995 and settled on Medisonbecause of that company's ultrasound manufacturing experienceand European marketing channels, the spokesperson said.

The companies declined to disclose financial terms of the purchase,which was completed last month. Medison plans to sell Kretztechniksystems through dealers, and is evaluating the company's currentdealer network, according to Mark Hayward, president of MedisonAmerica. It would like to maintain a relationship with Cone inthe U.S.

"Medison is going through a standard process of evaluatingdealers around the world," Hayward said. "

What Medison and Medison America are trying to do is cooperatein some way with Cone for U.S. distribution."

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.